Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients

Intestinal dysbiosis, characterized by a reduced Firmicutes/Bacteroidetes ratio, has been reported in systemic lupus erythematosus (SLE) patients. In this study, in vitro cultures revealed that microbiota isolated from SLE patient stool samples (SLE-M) promoted lymphocyte activation and Th17 differentiation from naïve CD4+ lymphocytes to a greater extent than healthy control-microbiota. Enrichment of SLE-M with Treg-inducing bacteria showed that a mixture of two Clostridia strains significantly reduced the Th17/Th1 balance, whereas Bifidobacterium bifidum supplementation prevented CD4+ lymphocyte over-activation, thus supporting a possible therapeutic benefit of probiotics containing Treg-inducer strains in order to restore the Treg/Th17/Th1 imbalance present in SLE. In fact, ex vivo analyses of patient samples showed enlarged Th17 and Foxp3+ IL-17+ populations, suggesting a possible Treg-Th17 trans-differentiation. Moreover, analyses of fecal microbiota revealed a negative correlation between IL-17+ populations and Firmicutes in healthy controls, whereas in SLE this phylum correlated directly with serum levels of IFNγ, a Th1 cytokine slightly reduced in patients. Finally, the frequency of Synergistetes, positively correlated with the Firmicutes/Bacteroidetes ratio in healthy controls, tended to be reduced in patients when anti-dsDNA titers were increased and showed a strong negative correlation with IL-6 serum levels and correlated positively with protective natural IgM antibodies against phosphorylcholine.

• Publication year

  2016

• Venue

  Scientific Reports

• Publication date

  2016-04-05

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1038/srep24072PMID 27044888PMCID 4820712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of Th17 cells by segmented filamentous bacteria in the murine intestine.

  2015cited by this paper
• Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.

  2015cited by this paper
• Bifidobacterium breve Attenuates Murine Dextran Sodium Sulfate-Induced Colitis and Increases Regulatory T Cell Responses

  2014cited by this paper
• Natural IgM: Beneficial Autoantibodies for the Control of Inflammatory and Autoimmune Disease

  2014cited by this paper
• Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus

  2014cited by this paper
• Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus.

  2014cited by this paper
• Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases

  2013cited by this paper
• Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

  2013cited by this paper
• Assessing the Fecal Microbiota: An Optimized Ion Torrent 16S rRNA Gene-Based Analysis Protocol

  2013cited by this paper
• Increased Prevalence of Circulating Novel IL-17 Secreting Foxp3 Expressing CD4+ T Cells and Defective Suppressive Function of Circulating Foxp3+ Regulatory Cells Support Plasticity Between Th17 and Regulatory T Cells in Inflammatory Bowel Disease Patients

  2013cited by this paper
• The Role of the Microbiome in Rheumatic Diseases

  2013cited by this paper
• Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity

  2013cited by this paper
• Gender bias in autoimmunity is influenced by microbiota.

  2013cited by this paper
• Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New

  2012cited by this paper
• Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus

  2012cited by this paper
• Interaction of Bifidobacterium bifidum LMG13195 with HT29 Cells Influences Regulatory-T-Cell-Associated Chemokine Receptor Expression

  2012cited by this paper
• MAPK phosphatase-1 is required for regulatory natural autoantibody-mediated inhibition of TLR responses

  2012cited by this paper
• Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species

  2011cited by this paper
• Immune Response to Bifidobacterium bifidum Strains Support Treg/Th17 Plasticity

  2011cited by this paper
• The role of bacteria and pattern-recognition receptors in Crohn's disease

  2011cited by this paper
• Regulatory T-cell stability and plasticity in mucosal and systemic immune systems

  2010cited by this paper
• The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients

  2010cited by this paper
• Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults

  2010cited by this paper
• Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis.

  2010cited by this paper
• Laser microdissection‐based analysis of cytokine balance in the kidneys of patients with lupus nephritis

  2010cited by this paper
• B cells as therapeutic targets in SLE

  2010cited by this paper
• Plasma IL-17A Is Increased in New-Onset SLE Patients and Associated with Disease Activity

  2010cited by this paper
• Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

  2010cited by this paper
• Distinct Bifidobacterium strains drive different immune responses in vitro.

  2010cited by this paper
• Foxp3+ regulatory T cells: differentiation, specification, subphenotypes

  2009cited by this paper
• Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

  2009cited by this paper
• IgM Antibodies to Apoptosis-Associated Determinants Recruit C1q and Enhance Dendritic Cell Phagocytosis of Apoptotic Cells1

  2009cited by this paper
• Inflammatory signals in dendritic cell activation and the induction of adaptive immunity

  2009cited by this paper
• Conserved anti-proliferative effect and poor inhibition of TNFalpha secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus.

  2009cited by this paper
• The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses.

  2009cited by this paper
• The gut microbiota shapes intestinal immune responses during health and disease

  2009cited by this paper
• Mechanisms of foxp3+ T regulatory cell-mediated suppression.

  2009cited by this paper
• Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1

  2008cited by this paper
• Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine.

  2008cited by this paper
• Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses.

  2008cited by this paper
• Innate immunity and intestinal microbiota in the development of Type 1 diabetes

  2008cited by this paper
• Natural antibodies against phosphorylcholine as potential protective factors in SLE.

  2008cited by this paper
• CD4 T cells: fates, functions, and faults.

  2008cited by this paper
• A microbial symbiosis factor prevents intestinal inflammatory disease

  2008cited by this paper
• Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

  2007cited by this paper
• Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus.

  2007cited by this paper
• Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1

  2007cited by this paper
• Orphanet Journal of Rare Diseases BioMed Central Review

  2006cited by this paper
• Systemic Lupus Erythematosus in Asturias, Spain: Clinical and Serologic Features

  2006cited by this paper
• Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.

  2006cited by this paper
• An obesity-associated gut microbiome with increased capacity for energy harvest

  2006cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features

  2003cited by this paper
• Quantification of bacterial subgroups in soil: comparison of DNA extracted directly from soil or from cells previously released by density gradient centrifugation.

  2001cited by this paper
• Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

  2001cited by this paper
• B1 B cell numbers and antibodies against phosphorylcholine and LPS are increased in IL-6 gene knockout mice.

  1999cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• The Old and the New

  1972cited by this paper

• Body Weight-Related Differences in Adipokines and Inflammatory Markers Among Women with Systemic Lupus Erythematosus.

  2026cites this paper
• The Role of the Gut Microbiome in Immune Regulation and Autoimmune and Allergic Diseases: Implications of Probiotics, Prebiotics, and Fecal Microbiota Transplantation

  2026cites this paper
• SCFAs’ pleiotropic role in pathogenesis and salutogenesis: mechanisms in exacerbation and regulation of inflammation and fibrosis from gut to host

  2026cites this paper
• Microbiome Differences in Preeclampsia Versus Lupus Nephritis

  2026cites this paper
• Therapeutic Potential of Irpex lacteus Polysaccharides in Lupus Nephritis: Insights From Gut Microbiota and Metabolomics Analysis in MRL/Lpr Mice

  2026cites this paper
• Identification of specific gut microbes and their therapeutic potential in ameliorating systemic lupus erythematosus in a mouse model.

  2025cites this paper
• Glycyrrhizin alleviates renal damage in MRL/lpr mice by modulating gut microbiota dysbiosis and regulating the RTK-PKCα axis: insights from reverse network pharmacology.

  2025cites this paper
• Gut microbiome in dermatology - A narrative review.

  2025cites this paper
• Characterization of Sex-Based Differences in Gut Microbiota That Correlate with Suppression of Lupus in Female BWF1 Mice

  2025cites this paper
• Microbial diversity investigation using 16S metagenomics in Tunisian patients with systemic lupus erythematosus.

  2025cites this paper
• The Gut Microbiota: Emerging Evidence in Autoimmune and Inflammatory Diseases

  2025cites this paper
• Advances in Traditional Chinese Medicine for Modulating DNA Methylation in the Treatment of Inflammatory Diseases

  2025cites this paper
• The role of the T helper 17 and T regulatory cell ratio in the thyroid gut axis

  2025cites this paper
• The Anti‐Lupus Plate: Mapping Nutritional Interventions to Inflammatory Pathways in Systemic Lupus Erythematosus

  2025cites this paper
• Systemic lupus erythematosus and the gut microbiome: To look forward is to look within - A systematic review and narrative synthesis.

  2025cites this paper
• Autoimmune diseases and microbiome targeted therapies.

  2025cites this paper
• The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target

  2025cites this paper
• Gut microbiota dysbiosis and associated immune response in systemic lupus erythematosus: impact of disease and treatment

  2025cites this paper
• Microbial Modulation of the Gut–Liver Axis in Autoimmune Liver Diseases

  2025cites this paper
• Immune metabolic restoration in systemic lupus erythematosus: the impact of gut microbiota, probiotics, and nutritional synergy

  2025cites this paper
• Beyond the microbiome: unraveling gut dysbiosis and its impact on systemic lupus erythematosus

  2025cites this paper
• The role of the gut microbiome in immune modulation: implications for autoimmune diseases and cancer therapy

  2025cites this paper
• Prediction of Relapse and Steroid Dependency in Pediatric Ulcerative Colitis

  2025cites this paper
• Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria

  2025cites this paper
• Pharmacological insights into gut microbiota modulation in systemic lupus erythematosus: Mechanisms, treatment strategies, and clinical implications.

  2025cites this paper
• Causal relationship between gut microbiome, immune cell, and systemic lupus erythematosus: A Mendelian randomization analysis

  2025cites this paper
• Exploring Gut Microbiota in Systemic Lupus Erythematosus: Insights and Biomarker Discovery Potential

  2025cites this paper
• The functional landscape of the appendix microbiome under conditions of health and disease

  2025cites this paper
• The role of probiotics in promoting systemic immune tolerance in systemic lupus erythematosus

  2025influential citation
• The Gut Microbiota–Sex–Immunity Axis in Non-Communicable Diseases

  2025cites this paper
• Effect of diet on the microbiota and immune system in patients with systemic lupus erythematosus

  2024cites this paper
• Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential

  2024cites this paper
• Interplay between the Chaperone System and Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus Pathogenesis: Is Molecular Mimicry the Missing Link between Those Two Factors?

  2024cites this paper
• The Microbiome Modifies Manifestations of Hemophagocytic Lymphohistiocytosis in Perforin‐Deficient Mice

  2024cites this paper
• Gut microbiome in the Graves’ disease: Comparison before and after anti-thyroid drug treatment

  2024cites this paper
• Lymphocytes Change Their Phenotype and Function in Systemic Lupus Erythematosus and Lupus Nephritis

  2024cites this paper
• Microbial dysbiosis in systemic lupus erythematosus: a scientometric study

  2024cites this paper
• Cow Placenta Extract Ameliorates Cyclophosphamide-Induced Intestinal Damage by Enhancing the Intestinal Barrier, Improving Immune Function, and Restoring Intestinal Microbiota

  2024cites this paper
• A double-edged sword: interactions of CX3CL1/CX3CR1 and gut microbiota in systemic lupus erythematosus

  2024cites this paper
• Gut microbiota regulation of T lymphocyte subsets during systemic lupus erythematosus

  2024cites this paper
• Human milk oligosaccharides in preventing food allergy: A review through gut microbiota and immune regulation.

  2024cites this paper
• Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation

  2024cites this paper
• Methods of Prevention and Mitigation of Autoimmune Diseases - A Review of The Literature

  2024cites this paper
• Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials

  2024cites this paper
• Prospects for microbiome modulation in autoimmune diseases: a literature review

  2024cites this paper
• The role of gut microbiota in different murine models of systemic lupus erythematosus

  2024influential citation
• CXCR3-Expressing T Cells in Infections and Autoimmunity.

  2024cites this paper
• The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases

  2024cites this paper
• Neutrophil extracellular traps as a potential marker of systemic lupus erythematosus activity.

  2024cites this paper
• Synergistic Interactions Between Gut Microbiota and Short Chain Fatty Acids: Pioneering Therapeutic Frontiers in Chronic Disease Management.

  2024cites this paper
• Roles of Probiotics, Prebiotics, and Postbiotics in B-cell mediated Immune Regulation.

  2024cites this paper
• Nuxcell Neo® improves vaccine efficacy in antibody response

  2024cites this paper
• Gut Microbiota and Autoimmune Diseases: Mechanisms, Treatment, Challenges, and Future Recommendations

  2024cites this paper
• Association of gut commensal translocation with autoantibody production in systemic lupus erythematosus.

  2024cites this paper
• Bifidobacterium in anticancer immunochemotherapy: friend or foe?

  2023cites this paper
• Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus

  2023cites this paper
• The function of human milk oligosaccharides and their substitute oligosaccharides as probiotics in gut inflammation.

  2023cites this paper
• Role of microbiota short-chain fatty acid chains in the pathogenesis of autoimmune diseases.

  2023cites this paper
• Genes and Microbiota Interaction in Monogenic Autoimmune Disorders

  2023cites this paper
• Microbiota Alterations in Patients with Mucous Membrane Pemphigoid and Pemphigus Vulgaris: A Systematic Review

  2023cites this paper
• Lupus Nephritis and Dysbiosis

  2023cites this paper
• Fecal microbiota transplantation improves chicken growth performance by balancing jejunal Th17/Treg cells

  2023cites this paper
• The microbiome and rheumatic heart disease: current knowledge and future perspectives

  2023cites this paper
• Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus

  2023cites this paper
• Alterations in the human oral microbiota in systemic lupus erythematosus

  2023cites this paper
• Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives

  2023cites this paper
• Intestinal involvement in lupus: From pathophysiology to therapeutic perspectives

  2023cites this paper
• T helper 17 (Th17) cell responses to the gut microbiota in human diseases.

  2023cites this paper
• Effects of intestinal microbes on rheumatic diseases: A bibliometric analysis

  2023cites this paper
• Probiotics and Prebiotics Orally Assumed as Disease Modifiers for Stable Mild Atopic Dermatitis: An Italian Real-Life, Multicenter, Retrospective, Observational Study

  2023cites this paper
• Gut Microbial Profile Differences in Autoimmune Diseases

  2023cites this paper
• Microbiota and Thyroid Disease: An Updated Systematic Review.

  2023cites this paper
• The potential pathogenic role of gut microbiota in rheumatic diseases: a human-centred narrative review

  2023cites this paper
• Perinatal events and development of juvenile idiopathic arthritis-associated uveitis

  2023cites this paper
• Bifidobacterium mitigates autoimmune hepatitis by regulating IL-33-induced Treg/Th17 imbalance via the TLR2/4 signaling pathway.

  2023cites this paper
• Nlrp12 deficiency alters gut microbiota and ameliorates Faslpr -mediated systemic autoimmunity in male mice

  2023cites this paper
• Altered gut microbiota and metabolites in untreated myasthenia gravis patients

  2023cites this paper
• Alterations of the gut microbiota in the lupus nephritis: a systematic review

  2023cites this paper
• Immunomagnetic Capture of Faecalibacterium prausnitzii Selectively Modifies the Fecal Microbiota and Its Immunomodulatory Profile

  2023cites this paper
• Possible Role of Dysbiosis of the Gut Microbiome in SLE

  2023cites this paper
• Bidirectional crosstalk between dysbiotic gut microbiota and systemic lupus erythematosus: What is new in therapeutic approaches?

  2022cites this paper
• Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases

  2022cites this paper
• Fluctuations in Intestinal Microbiota Following Ingestion of Natto Powder Containing Bacillus subtilis var. natto SONOMONO Spores: Considerations Using a Large-Scale Intestinal Microflora Database

  2022cites this paper
• Collinsella is associated with cumulative inflammatory burden in an established rheumatoid arthritis cohort.

  2022cites this paper
• Rebooting Regulatory T Cell and Dendritic Cell Function in Immune-Mediated Inflammatory Diseases: Biomarker and Therapy Discovery under a Multi-Omics Lens

  2022cites this paper
• Gut microbiota in systemic lupus erythematosus: A fuse and a solution.

  2022cites this paper
• In vivo Trial of Bifidobacterium longum Revealed the Complex Network Correlations Between Gut Microbiota and Health Promotional Effects

  2022cites this paper
• Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis

  2022cites this paper
• Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation

  2022cites this paper
• Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus-prone MRL/lpr mice

  2022cites this paper
• Fecal immunoglobulin A (IgA) and its subclasses in systemic lupus erythematosus patients are nuclear antigen reactive and this feature correlates with gut permeability marker levels

  2022cites this paper
• Bacteroides ovatus-mediated CD27− MAIT cell activation is associated with obesity-related T2D progression

  2022cites this paper
• New Pathophysiology Insight of Gut Microbiota’s Influence on Systemic Lupus Erythematosus: A Brief Review

  2022cites this paper
• Preclinical stage abundance and nuclear antigen reactivity of fecal Immunoglobulin A (IgA) varies among males and females of lupus-prone mouse models

  2022cites this paper
• The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis

  2022cites this paper
• Recent advances in systemic lupus erythematosus and microbiota: from bench to bedside

  2022cites this paper
• The Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology

  2022cites this paper
• The star target in SLE: IL-17

  2022cites this paper
• Targeting Regulatory T Cells for Therapy of Lupus Nephritis

  2022cites this paper
• Causal Relationship Between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study

  2022cites this paper